三诺生物(300298) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥618,238,116.56, representing an increase of 11.01% compared to the same period last year[2] - The net profit attributable to shareholders for Q3 2021 was ¥77,840,633.54, a decrease of 14.47% year-on-year[2] - The net profit after deducting non-recurring gains and losses was ¥74,606,709.47, down 14.61% from the previous year[2] - Total operating revenue for the period reached CNY 1,749,086,536.10, an increase of 14.4% compared to CNY 1,529,218,815.96 in the previous period[21] - Net profit for the period was CNY 196,550,398.85, a decrease of 21.2% from CNY 249,468,228.28 in the previous year[22] - The total profit for the period was CNY 215,710,379.12, down 30.9% from CNY 313,119,499.49 in the previous year[22] - Basic earnings per share decreased to CNY 0.3489 from CNY 0.4415 in the previous period, a decline of 20.9%[22] Assets and Liabilities - The total assets as of September 30, 2021, were ¥4,117,358,734.22, reflecting a growth of 5.68% compared to the end of the previous year[2] - Total current assets decreased to ¥1,681,374,992.68 from ¥1,782,056,307.86, a decline of about 5.7%[18] - Non-current assets increased to ¥2,435,983,741.54 from ¥2,113,884,764.46, reflecting an increase of approximately 15.2%[19] - Total liabilities rose to ¥1,280,105,025.62 from ¥1,154,867,507.58, marking an increase of approximately 10.8%[20] - The company's equity attributable to shareholders increased to ¥2,830,291,977.21 from ¥2,733,807,918.17, a rise of about 3.5%[20] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥190,619,407.31, a decline of 42.14% year-on-year[2] - The net cash flow from operating activities decreased by 42.14% to ¥190,619,407.31 compared to the previous year[7] - Cash received from tax refunds decreased by 41.35% to ¥21,132,926.18, primarily due to a reduction in tax refund amounts received by the parent company[7] - Total cash inflow from investment activities decreased by 85.71% to ¥154,026,505.00, mainly due to a reduction in cash recovered from time deposits[7] - Cash outflow from financing activities increased by 144.91% to ¥689,693,500.25, reflecting the overall impact of financing activities[7] - The net cash flow from investment activities was -418,218,197.06 CNY, compared to -173,220,264.90 CNY in the previous year, indicating a significant increase in cash outflow[24] - Total cash inflow from financing activities was 606,724,833.78 CNY, while cash outflow was 689,693,500.25 CNY, resulting in a net cash flow of -82,968,666.47 CNY[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,085[9] - As of September 30, 2021, the company repurchased a total of 3,095,187 shares, accounting for 0.55% of the total share capital of 564,768,137 shares, with a total transaction amount of RMB 82,016,452.55[11] - The company plans to use its own funds to repurchase shares with a total amount not exceeding RMB 200 million and not less than RMB 120 million, at a price not exceeding RMB 35.00 per share[11] - The first phase of the employee stock ownership plan holds 4,695,220 shares, representing 0.83% of the total share capital[14] - The second phase of the employee stock ownership plan grants 5,901,628 shares at a price of RMB 12.89 per share[15] Expenses - Sales expenses rose by 50.58% to ¥592,253,142.57, primarily due to increased advertising and promotional costs[6] - Research and development expenses increased to CNY 143,218,412.66, compared to CNY 131,862,923.39 in the previous period, reflecting a growth of 8.6%[21] Investment Activities - The company reported a significant increase in construction in progress, which rose by 291.19% to ¥166,019,829.65, attributed to increased project expenditures[4] - Cash paid for acquiring fixed assets and intangible assets increased by 82.00% to ¥329,144,702.06, driven by increased expenditures on the iPOCT industrial park project and CGM project equipment[7] - The company is focusing on expanding its investment activities, as indicated by the substantial cash outflows for asset acquisitions[24] Other Financial Metrics - The company reported a long-term investment of ¥287,757,676.32, down from ¥322,663,646.69, a decrease of about 10.8%[18] - The company’s inventory increased to ¥329,320,201.64 from ¥312,818,853.59, reflecting a growth of approximately 5.3%[18] - Other comprehensive income after tax was CNY 4,206,095.09, compared to a loss of CNY 28,838,225.88 in the previous year[22]